Israel - English - Ministry of Health

pfizer pharmaceuticals israel ltd - pegvisomant - powder and solvent for solution for injection - pegvisomant 30 mg/vial - pegvisomant - treatment of adult patients with acromegaly who have had an inadequate response to surgery and/or radiation therapy, and in whom an appropriate medical treatment with somatostatin analogues did not normalize igf-i concentrations or was not tolerated.

Israel - English - Ministry of Health

sanofi israel ltd - yellow fever virus strain 17d204 (substrain ab237) - powder and solvent for suspension for injection - yellow fever virus strain 17d204 (substrain ab237) - yellow fever, live attenuated - stamaril is indicated for active immunization against yellow fever in persons:• travelling to, passing through or living in an endemic area,• travelling to any country that requires an international certificate of vaccination for entry(which may or may not depend on the previous itinerary).• handling potentially infectious materials (e.g. laboratory personnel).see sections 4.2, 4.3 and 4.4 regarding the minimum age for vaccination of children under special circumstances and guidance for vaccination of other specific patient populations.in order to comply with vaccine regulations and to be officially recognized, yellow fever vaccines must be administered in an approved world health organization (who) vaccination centre and registered on an international certificate of vaccination. the validity period of thiscertificate is established according to international health regulations (ihr) recommendations, and starts 10 days after primary vaccination and immediately after re-vaccination (see section 4.2).

Israel - English - Ministry of Health

eli lilly israel ltd, israel - atomoxetine - solution (oral) - atomoxetine 4 mg / 1 ml - atomoxetine - strattera is indicated for the treatment of attention-deficit/hyperactivity disorder (adhd) in children of 6 years and older, in adolescents and in adults as part of a comprehensive treatment programme. treatment must be initiated by a specialist in the treatment of adhd, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. diagnosis should be made according to current dsm criteria or the guidelines in icd.in adults, the presence of symptoms of adhd that were pre-existing in childhood should be confirmed. third-party corroboration is desirable and strattera should not be initiated when the verification of childhood adhd symptoms is uncertain. diagnosis cannot be made solely on the presence of one or more symptoms of adhd. based on clinical judgment, patients should have adhd of at least moderate severity as indicated by at least moderate functional impairment in 2 or more settings (for example, social, academic, and/or occupational functioning), affecting several aspects of an individual’s life.

Israel - English - Ministry of Health

a.l. medi-market ltd. - gadoteric acid - solution for injection - gadoteric acid 279.32 mg / 1 ml - gadoteric acid - enhancement of contrast in magnetic resonance imaging. aencephalic and spinal pathologies: brain tumours tumours of the spine and the surrounding tissue intervertebral disk prolapse infectious diseases.abdominal pathologies: primary and secondary liver tumours. osteo-articular pathology: bone and soft tissue tumours synovial diseases.magnetic resonance imaging for angiography.

Israel - English - Ministry of Health

a. levy dental co. ltd, israel - cetrimide; lidocaine - solution - lidocaine 15 g / 100 g; cetrimide 0.15 g / 100 g - combinations - surface anaesthetic in dentistry.

Israel - English - Ministry of Health

a. levy dental co. ltd, israel - epinephrine as bitartrate; lidocaine hydrochloride ( as monohydrate) - solution for injection - epinephrine as bitartrate 12.5 mcg / 1 ml; lidocaine hydrochloride ( as monohydrate) 20 mg / 1 ml - lidocaine, combinations - for the production of local anaesthesia for dental procedures by infiltration or nerve block injections.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - eletriptan hydrobromide - film coated tablets - eletriptan hydrobromide 24.242 mg - eletriptan - acute treatment of the headache phase of migraine attacks, with or without aura.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - eletriptan hydrobromide - film coated tablets - eletriptan hydrobromide 48.485 mg - eletriptan - acute treatment of the headache phase of migraine attacks, with or without aura.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - eletriptan hydrobromide - film coated tablets - eletriptan hydrobromide 96.97 mg - eletriptan - acute treatment of the headache phase of migraine attacks, with or without aura.

Israel - English - Ministry of Health

pfizer pharmaceuticals israel ltd - meningococcus b, multicomponent vaccine; meningococcus b, multicomponent vaccine - suspension for injection - meningococcus b, multicomponent vaccine 60 mcg; meningococcus b, multicomponent vaccine 60 mcg - meningococcus b, multicomponent vaccine - trumenba is indicated for active immunisation of individuals 10 years and older to prevent invasive meningococcal disease caused by neisseria meningitidis serogroup b.